Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B T Troost

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Cardiothoracic and Vascular Anesthesia|September 6, 2000
Age and other risk factors for neuropsychologic decline in patients undergoing coronary artery bypass graft surgeryM H Smith, L E Wagenknecht, C Legault, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 6, 2000
A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgeryJ Butterworth, C Legault, D A Stump, et al.
Stroke|April 1, 1996
Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trialC Legault, C D Furberg, L E Wagenknecht, et al.
The Annals of Thoracic Surgery|June 1, 1997
Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass graftingJ W Hammon, D A Stump, N D Kon, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Cardiothoracic and Vascular Anesthesia|September 6, 2000
Age and other risk factors for neuropsychologic decline in patients undergoing coronary artery bypass graft surgeryM H Smith, L E Wagenknecht, C Legault, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 6, 2000
A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgeryJ Butterworth, C Legault, D A Stump, et al.
Stroke|April 1, 1996
Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trialC Legault, C D Furberg, L E Wagenknecht, et al.
The Annals of Thoracic Surgery|June 1, 1997
Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass graftingJ W Hammon, D A Stump, N D Kon, et al.
Pageof 8